Matthew Ros
Direttore/Membro del Consiglio presso COGENT BIOSCIENCES, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Matthew Ros
Società | Posizione | Inizio | Fine |
---|---|---|---|
COGENT BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 26/07/2019 | - |
Independent Dir/Board Member | 26/07/2019 | - |
Storia della carriera di Matthew Ros
Precedenti posizioni note di Matthew Ros
Società | Posizione | Inizio | Fine |
---|---|---|---|
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Direttore/Membro del Consiglio | 18/04/2022 | 01/08/2023 |
Amministratore Delegato | 18/04/2022 | 01/08/2023 | |
EPIZYME, INC. | Direttore operativo | 16/05/2016 | 30/09/2018 |
Direttore Finanziario/CFO | 16/07/2021 | 01/10/2021 | |
Corporate Officer/Principal | 30/09/2018 | 16/07/2021 | |
SANOFI | Direttore operativo | 01/12/2014 | 01/05/2016 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/09/2012 | 01/12/2014 |
SANOFI | Corporate Officer/Principal | 01/09/2010 | 01/09/2012 |
ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13/04/2009 | 01/06/2010 |
Vendite & Marketing | 01/10/2007 | 13/04/2009 | |
BRISTOL-MYERS SQUIBB COMPANY | Direttore/Membro del Consiglio | 01/01/1990 | 01/01/2007 |
Cancer Care, Inc.
Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Formazione di Matthew Ros
The State University of New York | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Director/Board Member | 4 |
Chief Operating Officer | 2 |
Settori
Health Technology | 8 |
Consumer Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
COGENT BIOSCIENCES, INC. | Health Technology |
SANOFI | Health Technology |
Aziende private | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Cancer Care, Inc.
Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Health Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Matthew Ros
- Esperienza